Literature DB >> 11093172

Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens.

G Denkberg1, C J Cohen, D Segal, A F Kirkin, Y Reiter.   

Abstract

Soluble recombinant MHC-peptide complexes are valuable tools for molecular characterization of immune responses as well as for other functional and structural studies. In this study, soluble recombinant single-chain human MHC (scMHC)-peptide complexes were generated by in vitro refolding of inclusion bodies from bacterially expressed engineered HLA-A2 in the presence of tumor-associated or viral peptides. The scMHC molecule was composed of beta2-microglobulin connected to the first three domains of the HLA-A2 heavy chain through a 15-amino acid flexible linker. Highly purified scMHC-peptide complexes were obtained in high yield using several peptides derived from the melanoma antigens gp100 and MART-1 or a viral peptide derived from HTLV-1. The scMHC complexes were characterized in detail and were found to be correctly folded and able to specifically bind HLA-A2-restricted peptides. We also generated scMHC-peptide tetramers, which were biologically functional; they induced a peptide-specific CTL clone to be activated and secrete IFN-gamma, and were able to stain specifically CTL lines. Such recombinant soluble scMHC-peptide complexes and tetramers should prove of great value for characterization of immune responses involving CTL, for visualization of antigen-specific immune responses, for in vitro primary CTL induction, and for peptide binding assays and structural studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093172     DOI: 10.1002/1521-4141(2000012)30:12<3522::AID-IMMU3522>3.0.CO;2-D

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.

Authors:  S I Mannering; F S Wong; I Durinovic-Belló; B Brooks-Worrell; T I Tree; C M Cilio; N C Schloot; R Mallone
Journal:  Clin Exp Immunol       Date:  2010-09-15       Impact factor: 4.330

2.  Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts.

Authors:  Eynav Klechevsky; Michael Gallegos; Galit Denkberg; Karolina Palucka; Jacques Banchereau; Cyril Cohen; Yoram Reiter
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

3.  Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.

Authors:  Galit Denkberg; Cyril J Cohen; Avital Lev; Patrick Chames; Hennie R Hoogenboom; Yoram Reiter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

4.  Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo.

Authors:  Avital Lev; Roy Noy; Kfir Oved; Hila Novak; Dina Segal; Peter Walden; Dietmar Zehn; Yoram Reiter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

5.  Greater expression of TLR2, TLR4, and IL6 due to negative energy balance is associated with lower expression of HLA-DRA and HLA-A in bovine blood neutrophils after intramammary mastitis challenge with Streptococcus uberis.

Authors:  Kasey M Moyes; James K Drackley; Dawn E Morin; Juan J Loor
Journal:  Funct Integr Genomics       Date:  2010-03       Impact factor: 3.410

6.  Mammary gene expression profiles during an intramammary challenge reveal potential mechanisms linking negative energy balance with impaired immune response.

Authors:  Kasey M Moyes; James K Drackley; Dawn E Morin; Sandra L Rodriguez-Zas; Robin E Everts; Harris A Lewin; Juan J Loor
Journal:  Physiol Genomics       Date:  2010-01-26       Impact factor: 3.107

Review 7.  Opportunities and Challenges for Antibodies against Intracellular Antigens.

Authors:  Xiaofeng Yang; Shenxia Xie; Xiaomei Yang; Juan C Cueva; Xiaoqiong Hou; Zhuoran Tang; Hua Yao; Fengzhen Mo; Shihua Yin; Aiqun Liu; Xiaoling Lu
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

8.  Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.

Authors:  Malka Epel; Irit Carmi; Sharon Soueid-Baumgarten; SangKon Oh; Tapan Bera; Ira Pastan; Jay Berzofsky; Yoram Reiter
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 6.688

9.  Selection of a Single Domain Antibody, Specific for an HLA-Bound Epitope of the Mycobacterial Ag85B Antigen.

Authors:  Paola A Ortega; Mayra Silva-Miranda; Alfredo Torres-Larios; Eduardo Campos-Chávez; Kees C L C M Franken; Tom H M Ottenhoff; Juraj Ivanyi; Clara Espitia
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.